| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
HEPA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 5.00M | $200.0K | - | |
| Dir | 1.25M | $50.0K | - | |
| CEO | 1.25M | $50.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Appajosyula Sireesh | Director | Buy | 1,250,000 | $0.04 | $50,000.00 | New | |
| Apr 21, 2026 | Stetz Gary S. | Interim CEO | Buy | 1,250,000 | $0.04 | $50,000.00 | New | |
| Apr 21, 2026 | Lopriore Vincent S | Executive Chairman | Buy | 6,250,000 | $0.04 | $250,000.00 | +125.0% | |
| Nov 27, 2023 | Wijngaard Peter | Director | Buy | 5,000 | $3.07 | $15,350.00 | +111.1% | |
| Sep 19, 2023 | Wijngaard Peter | Director | Buy | 3,000 | $5.61 | $16,841.12 | +199.9% | |
| Sep 18, 2023 | Foster Robert T | CEO And Director | Buy | 1,600 | $5.60 | $8,960.00 | +3.3% | |
| Sep 15, 2023 | Foster Robert T | CEO,CSO And Director | Buy | 1,600 | $5.40 | $8,640.00 | +3.4% | |
| Feb 18, 2021 | Foster Robert T | CEO And Director | Buy | 20,000 | $2.00 | $40,000.00 | +79.2% | |
| Feb 18, 2021 | Cavan John T | Chief Financial Officer | Buy | 10,000 | $2.00 | $20,000.00 | +208.3% | |
| Feb 16, 2021 | Wijngaard Peter | Director | Buy | 10,000 | $2.20 | $22,000.00 | +50.0% |